These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 10446117

  • 1. Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment.
    Rodrigues CM, Marín JJ, Brites D.
    Gut; 1999 Sep; 45(3):446-52. PubMed ID: 10446117
    [Abstract] [Full Text] [Related]

  • 2. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D.
    Ann Hepatol; 2002 Sep; 1(1):20-8. PubMed ID: 15114292
    [Abstract] [Full Text] [Related]

  • 3. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
    Brites D, Rodrigues CM.
    J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
    [Abstract] [Full Text] [Related]

  • 4. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G, Rizzo N, Azzaroli F, Simoni P, Bovicelli L, Miracolo A, Simonazzi G, Colecchia A, Nigro G, Mwangemi C, Festi D, Roda E.
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [Abstract] [Full Text] [Related]

  • 5. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 6. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C.
    BJOG; 2019 Dec; 126(13):1633-1640. PubMed ID: 31483939
    [Abstract] [Full Text] [Related]

  • 7. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F, Zhang L, He MM, Liu ZF, Gao BX, Wang XD.
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [Abstract] [Full Text] [Related]

  • 8. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM.
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [Abstract] [Full Text] [Related]

  • 9. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid.
    Geenes V, Lövgren-Sandblom A, Benthin L, Lawrance D, Chambers J, Gurung V, Thornton J, Chappell L, Khan E, Dixon P, Marschall HU, Williamson C.
    PLoS One; 2014 Jan; 9(1):e83828. PubMed ID: 24421907
    [Abstract] [Full Text] [Related]

  • 10. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 11. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J.
    Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
    [Abstract] [Full Text] [Related]

  • 12. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
    Glantz A, Marschall HU, Lammert F, Mattsson LA.
    Hepatology; 2005 Dec 27; 42(6):1399-405. PubMed ID: 16317669
    [Abstract] [Full Text] [Related]

  • 14. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 29; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V.
    Gastroenterology; 2012 Dec 29; 143(6):1492-501. PubMed ID: 22892336
    [Abstract] [Full Text] [Related]

  • 17. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial.
    Floreani A, Paternoster D, Melis A, Grella PV.
    Eur J Obstet Gynecol Reprod Biol; 1996 Aug 29; 67(2):109-13. PubMed ID: 8841797
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study.
    Cui Y, Xu B, Zhang X, He Y, Shao Y, Ding M.
    Clin Chim Acta; 2018 Aug 29; 483():135-141. PubMed ID: 29709452
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta.
    Serrano MA, Brites D, Larena MG, Monte MJ, Bravo MP, Oliveira N, Marin JJ.
    J Hepatol; 1998 May 29; 28(5):829-39. PubMed ID: 9625319
    [Abstract] [Full Text] [Related]

  • 20. Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.
    Estiú MC, Monte MJ, Rivas L, Moirón M, Gomez-Rodriguez L, Rodriguez-Bravo T, Marin JJ, Macias RI.
    Br J Clin Pharmacol; 2015 Feb 29; 79(2):316-29. PubMed ID: 25099365
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.